Heart Failure Models: Traditional and Novel Therapy

Mohamed A Haidara1, Abdullah S Assiri, Hanaa Z Yassin

  • 1Physiology, College of Medicine, King Khalid University, Abha, Saudi Arabia. haidaram@hotmail.com.

Insights

Experimental animal models are crucial for understanding cardiovascular disease (CVD) and heart failure (HF) pathophysiology, aiding treatment development. Various models, including induced heart failure and myocardial infarction, offer insights into cellular and molecular mechanisms.

Area of Science:

  • Cardiology
  • Translational Medicine
  • Animal Models

Background:

  • Cardiovascular disease (CVD) is a leading cause of global morbidity and mortality.
  • Experimental animal models have significantly advanced the understanding and management of CVD.
  • No single model perfectly replicates human heart failure (HF), but they provide essential insights.

Purpose of the Study:

  • To review various experimental animal models used in studying the pathophysiology of heart failure (HF).
  • To highlight how these models contribute to understanding cellular and molecular mechanisms of CVD.
  • To discuss the utility of different HF induction methods in research.

Main Methods:

  • Review of existing literature on experimental animal models for cardiovascular disease and heart failure.
  • Categorization of models based on animal species (large and small animals).
  • Description of different methods for inducing heart failure experimentally, including myocardial infarction, pressure loading, and volume loading.

Main Results:

  • Animal models, spanning from small rodents to large animals, offer valuable data on cellular and molecular aspects of CVD.
  • Induced HF models, such as those involving myocardial infarction, pressure, or volume loading, allow investigation of specific HF aspects.
  • Volume loading models are useful for studying electrolyte and hormone disturbances, while pressure loading models aid in understanding ventricular hypertrophy and vascular changes.

Conclusions:

  • Experimental animal models are indispensable tools for unraveling the complexities of cardiovascular disease and heart failure pathophysiology.
  • The selection of an appropriate animal model is critical for addressing specific research questions in HF.
  • Continued development and refinement of these models will further drive progress in CVD treatment strategies.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
582
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
611
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
628